Purpose: Two non-restorative options for low rectal cancer not invading the sphincter are the low Hartmann’s procedure (LH) or intersphincteric proctectomy (IP). The aim of this study was to compare postoperative morbidity with emphasis on pelvic abscesses after LH and IP. Methods: All patients that had LH or IP for low rectal cancer were included in three centres between 2008 and 2014 in this retrospective cohort study. Follow-up was performed for at least 12 months. Results: A total of 52 patients were included: 40 LH and 12 IP. Median follow-up was 29 months (IQR 23). There were no differences between groups in gender, age and ASA classification. Seven patients in the LH group (18%) and four patients in the IP group (33%) developed a complication within 30-day postoperative with a Clavien-Dindo classification grade III or higher (P = 0.253). Four out of 40 patients (10%) in the LH group and two out of 12 patients (17%) in the IP group developed a pelvic abscess (P = 0.612). Reinterventions were performed in 11 (28%) patients in the LH group and five (42%) patients in the IP group (P = 0.478), with a total number of reinterventions of 13 and 20, respectively. Six and 15 interventions were related to pelvic abscesses, respectively. Conclusion: Pelvic abscesses seem to occur in a similar rate after both LH and IP. Previous reports from the literature suggesting that IP might be associated with less infectious pelvic complications compared to LH are not supported by this study, although numbers are small.

Additional Metadata
Keywords Complications, Hartmann’s procedure, Intersphincteric proctectomy, Pelvic abscess, Rectal cancer, Surgery
Persistent URL dx.doi.org/10.1007/s00384-017-2886-5, hdl.handle.net/1765/101415
Journal International Journal of Colorectal Disease: clinical and molecular gastroenterology and surgery
Citation
Westerduin, E, Musters, G.D, van Geloven, A.A, Westerterp, M, van der Harst, E, Bemelman, W.A, & Tanis, P.J. (2017). Low Hartmann’s procedure or intersphincteric proctectomy for distal rectal cancer: a retrospective comparative cohort study. International Journal of Colorectal Disease: clinical and molecular gastroenterology and surgery, 1–7. doi:10.1007/s00384-017-2886-5